Litigation Details for BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2016)
✉ Email this page to a colleague
BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-12-22 |
Court | District Court, D. Delaware | Date Terminated | 2018-02-07 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 7,579,019; 8,147,866 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA Inc.
Details for BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-02-06 | 38 | United States Patent No. 7,579,019 ("the '019 patent") and United States Patent No. 8,147,…8,147,866 ("the '866 patent"), (collectively, "the Patents-in-Suit"), in connection…Court has subject matter jurisdiction over this patent infringement action (the "Action"). … Defendants acknowledge and agree that the Patents-in-Suit are valid, enforceable, and infringed…during the life of the '019 and '866 Patents, including any extensions and pediatric exclusivities | External link to document | |
2016-12-21 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,019 B2; 8,147,866 B2. (…2016 7 February 2018 1:16-cv-01303 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |